Merck EPS - Earnings per Share 2010-2024 | MKKGY
Merck annual and quarterly earnings per share history from 2010 to 2024. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
- Merck EPS for the quarter ending June 30, 2024 was $1.51, a 14.61% decline year-over-year.
- Merck EPS for the twelve months ending June 30, 2024 was $6.54, a 11.71% decline year-over-year.
- Merck 2023 annual EPS was $7.02, a 12.85% decline from 2022.
- Merck 2022 annual EPS was $8.06, a 3.09% decline from 2021.
- Merck 2021 annual EPS was $8.32, a 59.33% increase from 2020.
| Merck Annual EPS |
| 2023 |
$7.02 |
| 2022 |
$8.06 |
| 2021 |
$8.32 |
| 2020 |
$5.22 |
| 2019 |
$3.41 |
| 2018 |
$9.17 |
| 2017 |
$6.76 |
| 2016 |
$4.15 |
| 2015 |
$2.84 |
| 2014 |
$2.98 |
| 2013 |
$3.68 |
| 2012 |
$1.68 |
| 2011 |
$1.87 |
| 2010 |
$1.93 |
| 2009 |
$1.18 |
| Merck Quarterly EPS |
| 2024-06-30 |
$1.51 |
| 2024-03-31 |
$1.74 |
| 2023-12-31 |
$1.44 |
| 2023-09-30 |
$1.85 |
| 2023-06-30 |
$1.77 |
| 2023-03-31 |
$1.96 |
| 2022-12-31 |
$1.54 |
| 2022-09-30 |
$2.14 |
| 2022-06-30 |
$2.12 |
| 2022-03-31 |
$2.27 |
| 2021-12-31 |
$2.12 |
| 2021-09-30 |
$2.06 |
| 2021-06-30 |
$2.06 |
| 2021-03-31 |
$2.07 |
| 2020-12-31 |
$1.16 |
| 2020-09-30 |
$2.16 |
| 2020-06-30 |
$0.74 |
| 2020-03-31 |
$1.16 |
| 2019-12-31 |
$0.82 |
| 2019-09-30 |
$0.88 |
| 2019-06-30 |
$1.21 |
| 2019-03-31 |
$0.49 |
| 2018-12-31 |
$6.62 |
| 2018-09-30 |
$0.91 |
| 2018-06-30 |
$0.68 |
| 2018-03-31 |
$0.96 |
| 2017-12-31 |
$2.68 |
| 2017-09-30 |
$1.74 |
| 2017-06-30 |
$1.07 |
| 2017-03-31 |
$1.28 |
| 2016-12-31 |
$0.67 |
| 2016-09-30 |
$1.17 |
| 2016-06-30 |
$0.81 |
| 2016-03-31 |
$1.50 |
| 2015-12-31 |
$0.32 |
| 2015-09-30 |
$0.94 |
| 2015-06-30 |
$0.87 |
| 2015-03-31 |
$0.74 |
| 2014-12-31 |
$0.72 |
| 2014-09-30 |
$0.76 |
| 2014-06-30 |
$0.94 |
| 2014-03-31 |
$2.06 |
| 2013-12-31 |
$0.88 |
| 2013-09-30 |
$1.04 |
| 2013-06-30 |
$0.96 |
| 2013-03-31 |
$0.79 |
| 2012-12-31 |
$0.81 |
| 2012-09-30 |
$0.53 |
| 2012-06-30 |
$-0.18 |
| 2012-03-31 |
$0.51 |
| 2011-12-31 |
$0.41 |
| 2011-09-30 |
$0.74 |
| 2011-06-30 |
$-0.29 |
| 2011-03-31 |
$1.08 |
| 2010-12-31 |
$0.21 |
| 2010-09-30 |
$0.63 |
| 2010-06-30 |
$0.51 |
| 2010-03-31 |
$0.59 |
| 2009-12-31 |
$0.51 |
| 2009-09-30 |
$0.16 |
| 2009-06-30 |
$0.34 |
| 2009-03-31 |
$0.17 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$21.306B |
$22.719B |
|
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
|
